Search Back New search Go to resultsDiseaseMain groupSolid TumorsProtocol groupEndocrine and Neuroendocrine OncologyGastroenterologic OncologyDiseaseNeuroendocrine CarcinomaPancreatic CancerSubgroupICD10C25.-C80.9MeSHCarcinoma, NeuroendocrinePancreatic NeoplasmsSequenceChemotherapyChemo-substanceCapecitabineCisplatinEtoposideIrinotecanTemozolomideChemo-substanceCapecitabineCisplatinEtoposideIrinotecanTemozolomideChemo-substanceCapecitabineCisplatinEtoposideIrinotecanTemozolomideChemo-substanceCapecitabineCisplatinEtoposideIrinotecanTemozolomideNo. Substances2 RadiotherapySupportive therapySupportive substanceBalanced Crystalloid SolutionCotrimoxazoleDexamethasoneFilgrastimFosaprepitantGranisetronMagnesium sulfatePegfilgrastimPotassium chlorideSupportive substanceBalanced Crystalloid SolutionCotrimoxazoleDexamethasoneFilgrastimFosaprepitantGranisetronMagnesium sulfatePegfilgrastimPotassium chlorideSupportive substanceBalanced Crystalloid SolutionCotrimoxazoleDexamethasoneFilgrastimFosaprepitantGranisetronMagnesium sulfatePegfilgrastimPotassium chlorideSupportive substanceBalanced Crystalloid SolutionCotrimoxazoleDexamethasoneFilgrastimFosaprepitantGranisetronMagnesium sulfatePegfilgrastimPotassium chlorideNo. Substances37Protocol classificationTherapy classificationcurrent standardIntensityStandard doseTherapy indicationFirst lineTherapy phaseTherapy intentionpalliativeRisksAnemia Hb below 8g/dlAnemia Hb below 10g/dlAnorexiaCholangitisDiarrheaEmetogenicity (ASCO)Emetogenicity (MASCC/ESMO)FatigueFebrile NeutropeniaHypokalemiaHyponatremiaIncrease AminotransferasesNauseaNeutropeniaThrombocytopenia below 50 000/µl only studiesPublicationAuthorMorizane CStrosberg JRDiseaseNeuroendokrines Karzinom des Verdauungstraktes, nicht resezierbar, Erstlinie, ECOG 0-1pankreatisches neuroendokrines Karzinom, ErstlinieOriginDepartment of Gastrointestinal Oncology, H. Lee Moffitt Cancer Center and Research Institute, FloridaJapan Clinical Oncology Group (JCOG), TOPIC-NETProtocols in Revision 3 protocols foundProtocols under revision.Capecitabine 750 / Temozolomide 200, pancreatic neuroendocrine carcinoma (PID1313)Cisplatin 60 / Irinotecan 60, gastroenteral and pancreatic neuroendocrine carcinoma (PID2180)Cisplatin 80 / Etoposide 100, gastroenteral and pancreatic neuroendocrine carcinoma (PID2174)